yttrium-90 citrate

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1975-2016
01219752016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A 37-year-old male patient presented with right knee pain and swelling. The patient had a 6-year history of rheumatoid arthritis… (More)
Is this relevant?
2013
2013
Repeated bleeding in the joint cavities is the most annoying symptom and often has disabling effects in patients with hemophilia… (More)
Is this relevant?
2012
2012
Yttrium-90 radioembolisation (Y90-RE) is recommended for unresectable, chemorefractory liver-dominant disease; however, the… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2007
2007
UNLABELLED The aim of this study was to investigate the genotoxic effect on the peripheral blood lymphocytes potentially induced… (More)
Is this relevant?
2006
2006
UNLABELLED Radiosynoviorthesis (RSO) with the ss-particle-emitting nuclide yttrium-90 is an established concept for the treatment… (More)
Is this relevant?
2006
2006
The production of dicentric chromosomes in human lymphocytes by beta-particles of yttrium-90 (Y-90) was studied in vitro to… (More)
Is this relevant?
1997
1997
BACKGROUND There have been no major advances in the systemic detection of renal cell carcinoma (RCC) and its unpredictable… (More)
Is this relevant?
1996
1996
Yttrium-90 is used for palliative therapy for the treatment of skeletal metastases, but because it is a pure β- emitter, data on… (More)
  • figure 3
  • figure 2
  • figure 4
  • figure 5
  • figure 7
Is this relevant?
1975
1975
The preparation of an yttrium-90 citrate colloid is described. This formulation localizes in the synovial membrane and thereby… (More)
Is this relevant?